Why the study?
Do antiinflammatory and antioxidant agents prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
Do antiinflammatory and antioxidant agents prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
Answers are grounded in this paper and cite their sources.
Antiinflammatory and antioxidant agents show promise in preventing postoperative atrial fibrillation, but larger randomized trials are required to establish definitive efficacy and dosing.
Postoperative atrial fibrillation is the most common complication of cardiac surgery. It is associated with increased complication rates. Recent trials have suggested that inflammation and oxidative stress have key roles in the pathophysiology of atrial fibrillation. Current evidence evaluating the use of antiinflammatory and antioxidant agents, including statins, corticosteroids, N-acetylcysteine, vitamin C, and fish oil, to prevent postoperative atrial fibrillation is promising. However, larger randomized, controlled trials comparing different dose regimens are needed.
No takes yet. Share an insight, caveat, or question.
Mehmet Özaydın (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: